100 related articles for article (PubMed ID: 6756164)
21. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
Garvey WT; Revers RR; Kolterman OG; Rubenstein AH; Olefsky JM
J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
[TBL] [Abstract][Full Text] [Related]
22. Splanchnic glucose and amino acid metabolism in obesity.
Felig P; Wahren J; Hendler R; Brundin T
J Clin Invest; 1974 Feb; 53(2):582-90. PubMed ID: 11344573
[TBL] [Abstract][Full Text] [Related]
23. Peripheral insulin parallels changes in insulin secretion more closely than C-peptide after bolus intravenous glucose administration.
Shapiro ET; Tillil H; Rubenstein AH; Polonsky KS
J Clin Endocrinol Metab; 1988 Nov; 67(5):1094-9. PubMed ID: 3053748
[TBL] [Abstract][Full Text] [Related]
24. Elevated basal insulin secretion and normal dynamic insulin sensitivity in borderline hypertension.
Piccardo MG; Turchetti G; Rosa MS; Pacini G
Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):244-9. PubMed ID: 10656171
[TBL] [Abstract][Full Text] [Related]
25. Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia.
Ryan AS; Egan JM; Habener JF; Elahi D
J Clin Endocrinol Metab; 1998 Jul; 83(7):2399-404. PubMed ID: 9661618
[TBL] [Abstract][Full Text] [Related]
26. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.
Damjanovic SS; Lalic NM; Pesko PM; Petakov MS; Jotic A; Miljic D; Lalic KS; Lukic L; Djurovic M; Djukic VB
J Clin Endocrinol Metab; 2006 Jul; 91(7):2574-81. PubMed ID: 16621911
[TBL] [Abstract][Full Text] [Related]
27. Peripheral and hepatic insulin antagonism in hyperthyroidism.
Shen DC; Davidson MB; Kuo SW; Sheu WH
J Clin Endocrinol Metab; 1988 Mar; 66(3):565-9. PubMed ID: 3280588
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
[TBL] [Abstract][Full Text] [Related]
29. Insulin secretion and clearance. Comparison after oral and intravenous glucose.
Shapiro ET; Tillil H; Miller MA; Frank BH; Galloway JA; Rubenstein AH; Polonsky KS
Diabetes; 1987 Dec; 36(12):1365-71. PubMed ID: 3315785
[TBL] [Abstract][Full Text] [Related]
30. The metabolic clearance of insulin and the feedback inhibition of insulin secretion are altered with aging.
Fink RI; Revers RR; Kolterman OG; Olefsky JM
Diabetes; 1985 Mar; 34(3):275-80. PubMed ID: 3882495
[TBL] [Abstract][Full Text] [Related]
31. In nondiabetic, human immunodeficiency virus-infected patients with lipodystrophy, hepatic insulin extraction and posthepatic insulin clearance rate are decreased in proportion to insulin resistance.
Haugaard SB; Andersen O; Hansen BR; Andersen UB; Vølund A; Iversen J; Nielsen JO; Madsbad S
Metabolism; 2005 Feb; 54(2):171-9. PubMed ID: 15690310
[TBL] [Abstract][Full Text] [Related]
32. Basal and 24-h C-peptide and insulin secretion rate in normal man.
Kruszynska YT; Home PD; Hanning I; Alberti KG
Diabetologia; 1987 Jan; 30(1):16-21. PubMed ID: 3552817
[TBL] [Abstract][Full Text] [Related]
33. C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog.
Polonsky KS; Pugh W; Jaspan JB; Cohen DM; Karrison T; Tager HS; Rubenstein AH
J Clin Invest; 1984 Nov; 74(5):1821-9. PubMed ID: 6389599
[TBL] [Abstract][Full Text] [Related]
34. Splanchnic and extrasplanchnic extraction of insulin following oral and intravenous glucose loads.
Brundin T
Clin Sci (Lond); 1999 Oct; 97(4):429-36. PubMed ID: 10491343
[TBL] [Abstract][Full Text] [Related]
35. Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.
Mari A
Diabetologia; 1998 Sep; 41(9):1029-39. PubMed ID: 9754821
[TBL] [Abstract][Full Text] [Related]
36. The effects of biosynthetic human proinsulin on carbohydrate metabolism.
Revers RR; Henry R; Schmeiser L; Kolterman O; Cohen R; Bergenstal R; Polonsky K; Jaspan J; Rubenstein A; Frank B
Diabetes; 1984 Aug; 33(8):762-70. PubMed ID: 6378699
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction.
Polonsky K; Jaspan J; Pugh W; Cohen D; Schneider M; Schwartz T; Moossa AR; Tager H; Rubenstein AH
J Clin Invest; 1983 Sep; 72(3):1114-23. PubMed ID: 6350363
[TBL] [Abstract][Full Text] [Related]
38. Effect of verapamil on basal and glucagon-dependent splanchnic glucose metabolism and insulin secretion in man.
Gasić S; Bratusch-Marrain P; Waldhäusl W; Korn A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):36-40. PubMed ID: 3042640
[TBL] [Abstract][Full Text] [Related]
39. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration.
Vella A; Shah P; Basu R; Basu A; Camilleri M; Schwenk WF; Rizza RA
Diabetologia; 2001 Jun; 44(6):729-37. PubMed ID: 11440366
[TBL] [Abstract][Full Text] [Related]
40. Feedback inhibition of insulin secretion is altered in cirrhosis.
Cavallo-Perin P; Bruno A; Nuccio P; Goria M; Pagano G; Lenti G
J Clin Endocrinol Metab; 1986 Oct; 63(4):1023-7. PubMed ID: 3528209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
